Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study.

Nat Med · 2023 · PMC10427429 · PMID 37488291

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

approached significanceP = 0.051so close (0.05 < p ≤ 0.1)

Changes on the eating concern and dietary restraint subscales were not significant, but changes in eating concerns approached significance at 3-month follow-up ( P = 0.051, d = 0.71).

also in 2,355 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.